Free Trial

Waters Co. (NYSE:WAT) Receives $375.85 Average Price Target from Brokerages

Waters logo with Medical background

Waters Co. (NYSE:WAT - Get Free Report) has been assigned a consensus recommendation of "Hold" from the fourteen brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $375.85.

Several research analysts have issued reports on the company. Bank of America increased their price objective on Waters from $400.00 to $430.00 and gave the stock a "neutral" rating in a research report on Friday, December 13th. Sanford C. Bernstein boosted their price objective on shares of Waters from $345.00 to $360.00 and gave the stock a "market perform" rating in a report on Monday, November 4th. Stifel Nicolaus boosted their price target on Waters from $332.00 to $360.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Barclays raised their price objective on Waters from $330.00 to $360.00 and gave the company an "underweight" rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company upped their target price on Waters from $380.00 to $415.00 and gave the company an "overweight" rating in a report on Monday, November 4th.

Get Our Latest Analysis on WAT

Hedge Funds Weigh In On Waters

A number of large investors have recently modified their holdings of the company. Franklin Resources Inc. raised its stake in shares of Waters by 74.5% during the third quarter. Franklin Resources Inc. now owns 70,507 shares of the medical instruments supplier's stock valued at $25,189,000 after purchasing an additional 30,101 shares during the period. Tidal Investments LLC grew its stake in shares of Waters by 0.9% during the third quarter. Tidal Investments LLC now owns 3,998 shares of the medical instruments supplier's stock valued at $1,439,000 after acquiring an additional 36 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Waters in the third quarter worth about $100,000. Sanctuary Advisors LLC boosted its holdings in Waters by 25.2% in the third quarter. Sanctuary Advisors LLC now owns 2,433 shares of the medical instruments supplier's stock valued at $908,000 after purchasing an additional 490 shares during the last quarter. Finally, Toronto Dominion Bank grew its stake in Waters by 0.3% during the 3rd quarter. Toronto Dominion Bank now owns 26,303 shares of the medical instruments supplier's stock valued at $9,466,000 after purchasing an additional 69 shares in the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Stock Performance

Shares of WAT traded up $0.11 during mid-day trading on Wednesday, hitting $373.83. 81,760 shares of the company's stock were exchanged, compared to its average volume of 439,684. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. Waters has a fifty-two week low of $279.24 and a fifty-two week high of $397.02. The business's 50 day moving average is $366.82 and its two-hundred day moving average is $337.09. The firm has a market capitalization of $22.20 billion, a P/E ratio of 35.67, a P/E/G ratio of 6.92 and a beta of 1.01.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The company had revenue of $740.30 million for the quarter, compared to analysts' expectations of $712.99 million. During the same period in the previous year, the company posted $2.84 EPS. Waters's revenue was up 4.0% compared to the same quarter last year. On average, equities analysts expect that Waters will post 11.79 earnings per share for the current year.

About Waters

(Get Free Report

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Analyst Recommendations for Waters (NYSE:WAT)

Should you invest $1,000 in Waters right now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
3 Momentum Stock Picks With Room to Run

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines